Found: 25
Select item for more details and to access through your institution.
Are anti-calcitonin gene-related peptide monoclonal antibodies effective in treating migraine aura? A pilot prospective observational cohort study.
- Published in:
- Neurological Sciences, 2024, v. 45, n. 4, p. 1655, doi. 10.1007/s10072-023-07241-6
- By:
- Publication type:
- Article
Recurrent reflex syncope in idiopathic intracranial hypertension patient resolved after lumbar puncture: pathogenetic implications.
- Published in:
- BMC Neurology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12883-023-03451-9
- By:
- Publication type:
- Article
The C-Terminal Cross-linked Telopeptide of Type I Collagen (CTX-I) as a Potential Cardiomyopathy Biomarker in Friedreich Ataxia Patients.
- Published in:
- Cerebellum, 2023, v. 22, n. 5, p. 1034, doi. 10.1007/s12311-022-01475-4
- By:
- Publication type:
- Article
A head‐to‐head observational cohort study on the efficacy and safety of monoclonal antibodies against calcitonin gene–related peptide for chronic and episodic migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 6, p. 788, doi. 10.1111/head.14528
- By:
- Publication type:
- Article
Anti-calcitonin gene-related peptide monoclonal antibodies for the treatment of vestibular migraine: A prospective observational cohort study.
- Published in:
- Cephalalgia, 2023, v. 43, n. 4, p. 1, doi. 10.1177/03331024231161809
- By:
- Publication type:
- Article
Cognitive trajectories in multiple sclerosis: a long-term follow-up study.
- Published in:
- Neurological Sciences, 2022, v. 43, n. 2, p. 1215, doi. 10.1007/s10072-021-05356-2
- By:
- Publication type:
- Article
A real‐world study of alemtuzumab in a cohort of Italian patients.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 1, p. 257, doi. 10.1111/ene.15121
- By:
- Publication type:
- Article
Interplay Between Cognitive and Bowel/Bladder Function in Multiple Sclerosis.
- Published in:
- International Neurourology Journal, 2021, v. 25, n. 4, p. 310, doi. 10.5213/inj.2040346.173
- By:
- Publication type:
- Article
Pregnancy outcomes in alemtuzumab treated women with multiple sclerosis: a case series.
- Published in:
- Neurological Sciences, 2021, v. 42, n. 8, p. 3427, doi. 10.1007/s10072-020-04975-5
- By:
- Publication type:
- Article
The Framingham cardiovascular risk score and 5‐year progression of multiple sclerosis.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 3, p. 893, doi. 10.1111/ene.14608
- By:
- Publication type:
- Article
Predictors of Nabiximols (Sativex®) discontinuation over long-term follow-up: a real-life study.
- Published in:
- Journal of Neurology, 2020, v. 267, n. 6, p. 1737, doi. 10.1007/s00415-020-09739-x
- By:
- Publication type:
- Article
Post-mortem diagnosis of invasive pulmonary aspergillosis after alemtuzumab treatment for multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 1, p. 123, doi. 10.1177/1352458518813110
- By:
- Publication type:
- Article
Incidence and Predictive Risk Factors of Infective Events in Patients With Multiple Sclerosis Treated With Agents Targeting CD20 and CD52 Surface Antigens.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 11, p. N.PAG, doi. 10.1093/ofid/ofz445
- By:
- Publication type:
- Article
Outcomes after fingolimod to alemtuzumab treatment shift in relapsing–remitting MS patients: a multicentre cohort study.
- Published in:
- Journal of Neurology, 2019, v. 266, n. 10, p. 2440, doi. 10.1007/s00415-019-09424-8
- By:
- Publication type:
- Article
Dural sinus collapsibility, idiopathic intracranial hypertension, and the pathogenesis of chronic migraine.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Closing-in Phenomenon in Huntington's Disease: A Neuropsychological Marker of Frontal/Executive Dysfunction.
- Published in:
- Archives of Clinical Neuropsychology, 2019, v. 34, n. 1, p. 24, doi. 10.1093/arclin/acy020
- By:
- Publication type:
- Article
Cerebellum and cognition in progressive MS patients: functional changes beyond atrophy?
- Published in:
- Journal of Neurology, 2018, v. 265, n. 10, p. 2260, doi. 10.1007/s00415-018-8985-6
- By:
- Publication type:
- Article
Cardiovascular profile improvement during Natalizumab treatment.
- Published in:
- Metabolic Brain Disease, 2018, v. 33, n. 3, p. 981, doi. 10.1007/s11011-017-0169-z
- By:
- Publication type:
- Article
Functional MRI signal fluctuations highlight altered resting brain activity in Huntington's disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 9, p. 1289, doi. 10.1177/1352458516677592
- By:
- Publication type:
- Article
Healthcare Costs for Treating Relapsing Multiple Sclerosis and the Risk of Progression: A Retrospective Italian Cohort Study from 2001 to 2015.
- Published in:
- PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0169489
- By:
- Publication type:
- Article
Mobitz type I and II atrioventricular blocks during fingolimod therapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Modifications of resting state networks in spinocerebellar ataxia type 2.
- Published in:
- Movement Disorders, 2015, v. 30, n. 10, p. 1382, doi. 10.1002/mds.26284
- By:
- Publication type:
- Article
Default-Mode Network Changes in Huntington’s Disease: An Integrated MRI Study of Functional Connectivity and Morphometry.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0072159
- By:
- Publication type:
- Article
Course and outcome of a voltage-gated potassium channel antibody negative Morvan's syndrome.
- Published in:
- 2009
- By:
- Publication type:
- journal article